logo
How Julie Smolyansky built $200M kefir brand Lifeway Foods

How Julie Smolyansky built $200M kefir brand Lifeway Foods

Story Highlights At age 27, Julie Smolyansky became the youngest female CEO of a publicly traded company after her father's sudden death.
Despite remarkable success, Julie has faced intense challenges, including a family power struggle and a takeover attempt by Danone.
She turned her father's kefir startup into a global wellness brand, championing female empowerment, gut health, and cultural authenticity.
Julie Smolyansky's journey is the kind of story made for headlines — and heartbreak.
At just 27, she became the youngest female CEO of a publicly traded company, stepping into the leadership of Lifeway Foods after the sudden death of her father. A Soviet immigrant, wellness advocate and trailblazing entrepreneur, she transformed her family's modest kefir business into a global powerhouse, championing gut health, female empowerment and innovation along the way.
GET TO KNOW YOUR CITY
Find Local Events Near You
Connect with a community of local professionals.
Explore All Events
Under her leadership, Lifeway's annual revenue soared from $12 million in 2002 to nearly $200 million in 2024. In addition, the Chicago-area company (Nasdaq: LWAY) has expanded its distribution across the U.S. and internationally, reaching markets in Mexico, France, Ireland, and parts of Central and South America and the Caribbean.
Yet behind the scenes of Lifeway's remarkable growth — the company delivered its 22nd consecutive quarter of year-over-year net sales growth in the first quarter — Smolyansky has faced two incredibly difficult challenges as CEO: a deeply personal family rift in which her brother, Edward, and their mother, Ludmila, have launched a bid to oust her from the company she has led for more than two decades; and a takeover bid by French dairy giant Danone, which first invested in Lifeway in 1999 and currently owns just under 25% of the company's stock.
Despite those challenges, Smolyansky said she's proud of her determination 'to fight for what's right.'
'I know that I have the moral high ground in this situation,' she said. 'My father taught me to fight, and I didn't come this far to only go this far. I know that I am strong, I'm not afraid. I'm not going anywhere.
'We always were underestimated, yet here we are, 22 years later, about to be a $200 million company,' Smolyansky added. 'We have no debt. We have cash in the bank. We are sold nationwide, in every grocery store, and we are known for all the great things that we do in our communities and around the world.'
Bizwomen, an affiliated publication, talked with Smolyansky recently about her career journey, guiding a public company in the midst of multiple challenges and more.
Would you share more of your story from the time you and your family arrived in the U.S.?
My parents and I were refugees from a part of the world that is Ukraine today, but at the time it was called the Soviet Union. I was born in Kyiv at the height of the Cold War, and when I was born, my father made a promise to get me out of the country. He absolutely hated communism and felt stifled, suppressed and persecuted. So, he started a plan to get out of the Soviet Union, and when I turned 1, that plan was realized. We defected in the middle of the night, and we were exiled for three months while we waited for our green card and the approval to settle in the U.S.
We finally arrived in Chicago in August 1976 with just $116 in our pockets. My mother learned English watching 'General Hospital' like so many immigrant women. My father was an engineer by trade, and he was able to go through some of the Chicago alleyways and take broken electronics and repair them and then sell them for money. A few weeks later, he got an official job as a draftsman at an engineering firm, even though it was a demotion from what he was in the Soviet Union. But he continued to have aspirational dreams.
One day when we walked into the grocery store, my mother cried because she couldn't believe how much food there was. She and my father both grew up in scarcity in the Soviet Union and had to go to bread lines.
Knowing that there's a difference in the Slavic Eastern European food, she opened up the first Eastern European deli in Chicago's Rogers Park two years after we settled. Rogers Park really became ground central for all immigrants who were escaping from the Soviet Union. And that sort of started her entry into the food industry.
By 1985, she already had a handful of delis and was importing and distributing Eastern European food to other delis around the country, in places where Eastern European Soviet immigrants were settling around the United States.
Kefir is a 2,000-year-old staple from my ancestors, a recipe that was passed down generation to generation. It is an ancient fermenting process that has been known intuitively by my ancestors to have beneficial healing properties.
So, my father was like, 'Wow, America has everything, but it doesn't have kefir.' Someone told him, 'Why don't you design a plant, and I'll sell the kefir through my distribution network?' And just like that, six months later, Lifeway Foods was incorporated.
My father started making kefir in our basement. I was 11 years old the first time I tried the very first spoonful of Lifeway Kefir in America. He was able to get in touch with my grandmother, still in the Soviet Union at the time, and ask her to send bacterial cultures through a care package, and then we recreated that bacteria. It was real, authentic cultures that my ancestors really nurtured.
My father continued to grow Lifeway and became the first Soviet immigrant to take a company public in 1988.
Did you always dream of taking over the company one day?
I actually was going to be a psychologist. I was an in-home mental health family counselor with kids. I also was a certified rape crisis counselor.
But then serendipitously, I ended up in my father's office and found out about the impact of kefir and all the good things that it could do for people. Something went off in my head where I realized I could actually channel my passions for helping people and improving the world by bringing positive things to people through a for-profit business.
It made me proud to help my dad. I really saw all the good that he was doing. Instead of resisting his queries about coming to work with him and helping him, I left grad school after my first year, went to work with him side by side for five years and got to know him in a new way. He was my greatest advocate and encouraged me go as far as I could.
Lifeway was growing at the time and was a $6 million company when I came to work for him. But in 2002, he had a sudden heart attack and passed away at the age of 55. I was I just 27, and I became the youngest female CEO of a publicly traded company. But it was devastating.
My father's best friend said there's no way a 27-year-old girl could run this company and encouraged people to sell their stock. The next day, Nasdaq halted trading because the stock was collapsing. Despite all that, the board eventually voted me in as CEO.
What differentiates Lifeway Kefir from its competitors?
Our original recipe, for starters. That's No. 1. We have a whole variety of different kinds of milk, so whether you want grass-fed or organic or conventional, there's really something for everyone. We have a very diversified portfolio, making sure that no matter who you are, you can have access to our products. We have the most active culture product out there in the marketplace. We also are laser-focused on what we do.
There are a lot of dairy companies that have a surplus of dairy, so they make milk, and they make butter, and they make this, and they make that, and they're just like, 'Oh, let's put kefir in the mix,' but it's just another dairy product for them. We're 100% laser-focused on kefir.
You've had several challenges in your career journey, including the ongoing battle with family members for control of the company. How do you handle challenges as CEO of Lifeway?
One of the greatest challenges any CEO faces is leading through uncertainty while staying true to a clear vision. Over the years, we've had to navigate everything from global disruptions like the pandemic to rapidly shifting consumer preferences and economic headwinds.
For me, effective leadership has meant staying adaptable, fostering resilience within our team and communicating transparently, even when the path ahead isn't clear. Balancing short-term pressures with long-term strategy is never easy, but Lifeway's mission to nourish communities and promote wellness has always kept us grounded and focused.
Are you doing anything new for 2025?
We have a series of new items. We're launching a probiotic kefir-based salad dressing. We're also launching a collagen kefir that's got 5 grams of collagen. And we're launching a whole milk conventional line and premium dairy. We are introducing 10 new flavors that are really cool and trendy, like pistachio, rose vanilla and pink dragon fruit.
Any advice for other women entrepreneurs?
Don't give up. Keep going and know what you stand for. And always trust your gut. It won't steer you wrong.
Lifeway Foods
Top official: Julie Smolyansky, CEO
About: The Morton Grove, Illinois-based company — founded in 1986 — is a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.
Q1 data: Net sales were $46.1 million for the first quarter ended March 31, 2025, an increase of $1.5 million or 3.3% from the same period in 2024. The company reported net income of $3.5 million or 23 cents per basic and diluted common share for Q1 2025.
Cindy Barth is a freelance journalist based in Lexington, Kentucky. Reach her at cindyjbarth@gmail.com.
Sign up for the Business Journal's free daily newsletter to receive the latest business news impacting Chicago.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025
Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025

Yahoo

time33 minutes ago

  • Yahoo

Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025

SOUTH SAN FRANCISCO, Calif., June 12, 2025--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will host a conference call and webcast on Tuesday, June 17, 2025, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to report results for its fiscal year 2025 ended March 31, 2025, and provide a corporate update. The conference call is being webcast live, and a link can be found under "Events" in the Investors section of the Company's website. Participants may register to join the live call by following the link here to receive the dial-in numbers and unique PIN to access the call. Those who plan on participating are advised to join 15 minutes prior to the start time. A webcast replay of the call will be available on Vistagen's website about 24 hours after the end of the live conference call and will be accessible for at least 30 days. About Vistagen Headquartered in South San Francisco, CA, Vistagen (Nasdaq: VTGN) is a late clinical-stage biopharmaceutical company leveraging a deep understanding of nose-to-brain neurocircuitry to develop and commercialize a broad and diverse pipeline of clinical-stage product candidates from a new class of intranasal product candidates called pherines. Pherines specifically and selectively bind as agonists to peripheral receptors on human nasal chemosensory neurons and are designed to rapidly activate olfactory bulb-to-brain neurocircuits believed to regulate brain areas involved in behavior and autonomic nervous system activity. They are designed to achieve therapeutic benefits without requiring absorption into the blood or uptake into the brain, giving them the potential to be a safer alternative to other pharmacological options if successfully developed and approved. Vistagen's neuroscience pipeline also includes an oral prodrug with potential to treat certain neurological conditions involving the NMDA receptor. Vistagen is passionate about developing transformative treatment options to improve the lives of individuals underserved by the current standard of care for multiple highly prevalent indications, including social anxiety disorder, major depressive disorder, and multiple women's health conditions, including vasomotor symptoms (hot flashes) associated with menopause. Connect at View source version on Contacts Investor Inquiries: Mark A. McPartlandmarkmcp@ Media Inquiries: Michelle P. Wellingtonmwellington@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

New to The Street Signs Backstage ($ BKS) to 12-Part Media Series Covering Music, Sports, and Tokenized Real-World Assets in Entertainment
New to The Street Signs Backstage ($ BKS) to 12-Part Media Series Covering Music, Sports, and Tokenized Real-World Assets in Entertainment

Indianapolis Star

time42 minutes ago

  • Indianapolis Star

New to The Street Signs Backstage ($ BKS) to 12-Part Media Series Covering Music, Sports, and Tokenized Real-World Assets in Entertainment

NEW YORK CITY, NY / ACCESS Newswire New to The Street, a leading multi-platform media brand for business and financial television, proudly announces the signing of Backstage (NASDAQ:BKS) to an exclusive 12-part national media series. This powerful media rollout will include monthly long-form interviews, earned media coverage, national television commercials, and Times Square outdoor billboards, reaching over 220 million homes weekly through New to The Street 's distribution across Bloomberg, Fox Business as sponsored programming, and its fast-growing 2.7M+ subscriber YouTube channel. Backstage will be featured across all New to The Street platforms as an 'Opportunity To Consider™', with full editorial support and visibility as the company pioneers real-world utility and mainstream adoption of tokenized entertainment through $BKS. With partnerships already underway across music, sports, and live events, Backstage is rapidly building one of the most comprehensive ecosystems in Entertainment 3.0, positioning itself as a global innovator in tokenized real-world assets (RWA) in the entertainment sector. 'Backstage is unlocking a new era for fans, artists, and event organizers,' said Vince Caruso, CEO of New to The Street. 'We're excited to amplify their story and give them national visibility as they reshape the future of live experiences through digital infrastructure and Web3 technology.' The campaign begins this month, with first filming in June, followed by a series of national T.V. broadcasts and NYC-based investor and industry events. About Backstage (NASDAQ:BKS): Backstage is an Entertainment 3.0 platform built for fans, artists, and event organizers. It enables users to book tickets, hotels, and flights while earning and spending $BKS tokens. Focused on real-world utility and mainstream adoption, Backstage is shaping the future of live experiences-where fans don't just follow the crowd, they drive it. For the first time, artists and event organizers can capture value from the parallel economy their events generate-hotels, travel, local spending, and digital engagement-transforming previously untapped influence into new revenue streams. About New to The Street: New to The Street is a premier financial media platform combining sponsored television programming, earned media coverage, and iconic outdoor advertising. With content distributed on Bloomberg, Fox Business, and YouTube, the platform helps public and private companies reach investors, media, and consumers with unmatched scale and credibility. Media Contact: Alessio Piras ap@ Monica Brennan monica@ SOURCE: New To The Street View the original press release on ACCESS Newswire

Stocks slump and oil prices jump as Trump urges Iran's unconditional surrender
Stocks slump and oil prices jump as Trump urges Iran's unconditional surrender

Los Angeles Times

timean hour ago

  • Los Angeles Times

Stocks slump and oil prices jump as Trump urges Iran's unconditional surrender

NEW YORK — U.S. stocks slumped on Tuesday under the weight of another jump for the price of oil. It was a return to form for financial markets after Wall Street's worries about Israel's fighting with Iran had seemed to calm a bit on Monday. The Standard & Poor's 500 fell 0.8% following signals that the Israel-Iran conflict may be worsening and that one of the U.S. economy's main engines is weakening. The swing sent Wall Street's main measure of health nearly back to where it started the week. The Dow Jones Industrial Average dropped 299 points, or 0.7%, and the Nasdaq composite fell 0.9%. Stocks sank under increasing pressure from crude oil prices, which climbed in their latest see-saw move. A barrel of benchmark U.S. crude jumped 4.3% to $74.84. Brent crude, the international standard, added 4.4% to $76.45 per barrel. Their gains accelerated after President Trump raised the temperature on Israel's fight with Iran by calling for 'UNCONDITIONAL SURRENDER!' on his social media platform and saying, 'We are not going to' kill Iran's leader, 'at least for now.' Before that, Trump had left a Group of Seven summit early and warned that people in Iran's capital should evacuate immediately. It took only about eight hours for Trump to go from suggesting a nuclear deal with Iran remained 'achievable' to urging Tehran's 9.5 million residents to flee for their lives. The fighting has the potential to drive up prices for crude oil and gasoline because Iran is a major producer of oil, and it sits on the narrow Strait of Hormuz, through which much of the world's crude passes. Past conflicts in the area have caused spikes in oil prices, though they've historically proven to be only temporary after showing that they did not disrupt the flow of oil. Often, higher oil prices can help stocks of companies in the solar industry because they increase the incentive to switch to alternative energy sources. But solar stocks tumbled Tuesday because of the possibility that Congress may phase out tax credits for solar, wind and other energy sources that produce fewer emissions that change the Earth's climate. Enphase Energy dropped 24%, and First Solar fell 17.9%. Treasury yields also fell in the bond market after a report said shoppers spent less last month at U.S. retailers than the month before and than economists expected. Solid such spending has been one of the linchpins keeping the economy out of a recession, but part of May's drop may have simply been a return to more normal trends. In April, some shoppers had rushed to buy automobiles to get ahead of Trump's tariffs. 'Today's data suggests consumers are downshifting, but they haven't yet slammed the brakes,' according to Ellen Zentner, chief economic strategist for Morgan Stanley Wealth Management On the winning side of Wall Street was Jabil, which jumped 8.9% after reporting a stronger profit for the latest quarter than analysts expected. CEO Mike Dastoor credited strength from accelerated demand related to artificial-intelligence technology, among other things. Verve Therapeutics soared 81.5% after Eli Lilly said it would buy the company developing genetic medicines for cardiovascular disease in a $1 billion deal that could be worth up to $1.3 billion if certain conditions are met. Lilly's stock fell 2%. All told, the S&P 500 lost 50.39 points to 5,982.72. The Dow Jones Industrial Average dropped 299.29 to 42,215.80, and the Nasdaq composite sank 180.12 to 19,521.09. All the action took place as the Federal Reserve began a two-day meeting on interest rates. The nearly unanimous expectation among traders and economists is that the Fed will make no move. The Fed has been hesitant to lower interest rates, and it's been on hold this year after cutting at the end of last year, because it's waiting to see how much Trump's tariffs will hurt the economy and raise inflation. Inflation has remained relatively tame recently, and it's near the Fed's target of 2%. More important for financial markets on Wednesday will likely be the latest set of forecasts that Fed officials will publish for where they see the economy and interest rates heading in upcoming years. In the bond market, the yield on the 10-year Treasury eased to 4.38% from 4.46% late Monday. In stock markets abroad, indexes fell across much of Europe after finishing mixed in Asia. Tokyo's Nikkei 225 index rose 0.6% after the Bank of Japan opted to keep its key interest rate unchanged. It's been gradually raising its rate from near zero and cutting back on its purchases of Japanese government bonds to help counter inflation. Choe writes for the Associated Press.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store